These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25745053)

  • 1. αvβ6 integrin may be a potential prognostic biomarker in interstitial lung disease.
    Saini G; Porte J; Weinreb PH; Violette SM; Wallace WA; McKeever TM; Jenkins G
    Eur Respir J; 2015 Aug; 46(2):486-94. PubMed ID: 25745053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical SPECT/CT imaging of αvβ6 integrins for molecular stratification of idiopathic pulmonary fibrosis.
    John AE; Luckett JC; Tatler AL; Awais RO; Desai A; Habgood A; Ludbrook S; Blanchard AD; Perkins AC; Jenkins RG; Marshall JF
    J Nucl Med; 2013 Dec; 54(12):2146-52. PubMed ID: 24167080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of αvβ6 and αvβ1 integrin inhibition for treatment of idiopathic pulmonary fibrosis.
    Bellani S; Molyneaux PL; Maher TM; Spagnolo P
    Expert Opin Ther Targets; 2024 Jul; 28(7):575-585. PubMed ID: 38949181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease.
    Wilkinson AL; John AE; Barrett JW; Gower E; Morrison VS; Man Y; Pun KT; Roper JA; Luckett JC; Borthwick LA; Barksby BS; Burgoyne RA; Barnes R; Fisher AJ; Procopiou PA; Hatley RJD; Barrett TN; Marshall RP; Macdonald SJF; Jenkins RG; Slack RJ
    Eur J Pharmacol; 2021 Dec; 913():174618. PubMed ID: 34762934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical quantification of the integrin αvβ6 by [
    Lukey PT; Coello C; Gunn R; Parker C; Wilson FJ; Saleem A; Garman N; Costa M; Kendrick S; Onega M; Kang'ombe AR; Listanco A; Davies J; Ramada-Magalhaes J; Moz S; Fahy WA; Maher TM; Jenkins G; Passchier J; Marshall RP
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):967-979. PubMed ID: 31814068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usual interstitial pneumonia and smoking-related interstitial fibrosis display epithelial to mesenchymal transition in fibroblastic foci.
    Fabro AT; Minatel IO; Rangel MP; Halbwedl I; Parra ER; Capelozzi VL; Popper H
    Respir Med; 2014 Sep; 108(9):1377-86. PubMed ID: 25066934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis.
    John AE; Graves RH; Pun KT; Vitulli G; Forty EJ; Mercer PF; Morrell JL; Barrett JW; Rogers RF; Hafeji M; Bibby LI; Gower E; Morrison VS; Man Y; Roper JA; Luckett JC; Borthwick LA; Barksby BS; Burgoyne RA; Barnes R; Le J; Flint DJ; Pyne S; Habgood A; Organ LA; Joseph C; Edwards-Pritchard RC; Maher TM; Fisher AJ; Gudmann NS; Leeming DJ; Chambers RC; Lukey PT; Marshall RP; Macdonald SJF; Jenkins RG; Slack RJ
    Nat Commun; 2020 Sep; 11(1):4659. PubMed ID: 32938936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of HNF4α expression in interstitial lung disease.
    Sawazumi T; Baba T; Iwasawa T; Arai H; Matsumura M; Takemura T; Sugiyama M; Sekiya M; Saigusa Y; Ogura T; Inayama Y; Ohashi K; Okudela K
    Pathol Int; 2022 Jan; 72(1):25-34. PubMed ID: 34643024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.
    Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
    Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin αvβ6 predicts poor prognosis and promotes resistance to cisplatin in hilar cholangiocarcinoma.
    Sun Q; Dong X; Shang Y; Sun F; Niu J; Li F
    Pathol Res Pract; 2020 Jul; 216(7):153022. PubMed ID: 32534716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clubbing in patients with fibrotic interstitial lung diseases.
    van Manen MJG; Vermeer LC; Moor CC; Vrijenhoeff R; Grutters JC; Veltkamp M; Wijsenbeek MS
    Respir Med; 2017 Nov; 132():226-231. PubMed ID: 29229102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between fibroblastic foci profusion and high resolution CT morphology in fibrotic lung disease.
    Walsh SL; Wells AU; Sverzellati N; Devaraj A; von der Thüsen J; Yousem SA; Colby TV; Nicholson AG; Hansell DM
    BMC Med; 2015 Sep; 13():241. PubMed ID: 26399508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
    Popov Y; Patsenker E; Stickel F; Zaks J; Bhaskar KR; Niedobitek G; Kolb A; Friess H; Schuppan D
    J Hepatol; 2008 Mar; 48(3):453-64. PubMed ID: 18221819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical significance and underlying correlation of pStat-3 and integrin αvβ6 expression in gallbladder cancer.
    Enyu L; Na W; Chuanzong Z; Ben W; Xiaojuan W; Yan W; Zequn L; Jianguo H; Jiayong W; Benjia L; Cheng P; Min Z; Zongli Z
    Oncotarget; 2017 Mar; 8(12):19467-19477. PubMed ID: 28061445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin αvβ6 Positron Emission Tomography Imaging in Lung Cancer Patients Treated With Pulmonary Radiation Therapy.
    Saleem A; Helo Y; Win Z; Dale R; Cook J; Searle GE; Wells P
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):370-376. PubMed ID: 32060008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active remodeling in idiopathic interstitial pneumonias: evaluation of collagen types XII and XIV.
    Tzortzaki EG; Koutsopoulos AV; Dambaki KI; Lambiri I; Plataki M; Gordon MK; Gerecke DR; Siafakas NM
    J Histochem Cytochem; 2006 Jun; 54(6):693-700. PubMed ID: 16461366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor.
    Maher TM; Simpson JK; Porter JC; Wilson FJ; Chan R; Eames R; Cui Y; Siederer S; Parry S; Kenny J; Slack RJ; Sahota J; Paul L; Saunders P; Molyneaux PL; Lukey PT; Rizzo G; Searle GE; Marshall RP; Saleem A; Kang'ombe AR; Fairman D; Fahy WA; Vahdati-Bolouri M
    Respir Res; 2020 Mar; 21(1):75. PubMed ID: 32216814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
    Makino S
    Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin αvβ6 mediates epithelial-mesenchymal transition in human bronchial epithelial cells induced by lipopolysaccharides of Pseudomonas aeruginosa via TGF-β1-Smad2/3 signaling pathway.
    Liu W; Sun T; Wang Y
    Folia Microbiol (Praha); 2020 Apr; 65(2):329-338. PubMed ID: 31243731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.